Gossamer Bio (GOSS) Other Working Capital Changes (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Other Working Capital Changes of -$9.0 million for Q1 2026, down 547.29% year-over-year from $2.0 million in Q1 2025, and down 513.15% quarter-over-quarter from -$1.5 million in Q4 2025.
Gossamer Bio (GOSS) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Gossamer Bio's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$9.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 547.29% year-over-year to -$9.0 million; the TTM figure through Mar 2026 stood at -$13.9 million (down 125.48% YoY), while the FY2025 annual figure was -$6.3 million, down 111.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$9.0 million, down from -$1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $6.3 million in Q3 2023, with the low at -$4.4 million in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$5000.0 (2024), against an average of $417470.6.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes surged 82.17% in 2025, then plunged 547.29% in 2026.
- Gossamer Bio's Other Working Capital Changes stood at -$8.2 million in 2024, then soared by 82.17% to -$1.5 million in 2025, then slumped by 513.15% to -$9.0 million in 2026.
- Business Quant data shows GOSS's Other Working Capital Changes at -$9.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Gossamer Bio | 49.15 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.48 Mn |
| Jun 30, 2026 | -6.48 Mn |
| Jun 30, 2026 | -6.48 Mn |
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -4.37 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Jun 30, 2025 | -826,000.00 |
| Jun 30, 2025 | -826,000.00 |
| Jun 30, 2025 | -826,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |